A couple of days back saw the inauguration ceremony of "Asha Nivas" at @ACTREC_TMC by Hon'ble CM of Maharashtra @OfficeofUT@CMOMaharashtra and @sudhamurty in the presence of Shri K N Vyas @DAEIndia and Prof R A Badwe, Director, Tata Memorial Centre. Why is this such a big deal?
Let me explain-Asha Nivas is a place where patients treated at @TataMemorial and @ACTREC_TMC can stay during their cancer treatment. Consider that 86% of patients being treated by us come from outside Mumbai, 60% from outside Maharashtra, 65% hailing from low socioeconomic strata
Costs of living in a city like Mumbai can often be a bigger deterrent than costs of cancer treatment, with the result that many patients even with curable cancers abandon their treatment. Providing them with a convenient, hygienic and safe place to stay is important
We know from our experience that providing these arrangements to patients work well. @StJudeChildCare has provided similar facilities for children getting cancer treatment (9 cities, 37 centres) and this lowered treatment abandonment rates from 30% to less than 5%!
While most of us treating cancer focus on the treatment itself, we fail to realize that access & affordability are often not just related to costs of medicines, surgery and radiation
If we are to improve outcomes of cancer care, we need to think and provide solutions holistically
Which is why "Asha Nivas" is such a big deal. Funded generously by Infosys Foundation chaired by Mrs Sudha Murty, this will undoubtedly bring hope & succour to millions of patients over the years
On behalf of all the patients who will benefit, we are very grateful for the support
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This is such an important concept to understand. Very often, the public & even a lot of physicians equate the success of a screening test to detecting cancers early when patients are asymptomatic / improved survival amongst those detected to have cancer. This is inherently flawed
Why are early detection & improved survival not sufficient to proclaim success of a screening test?
While it seems intuitive, these two do not actually translate into lives saved
This doesn't seem logical, but it's true
This is because all cancers are not lethal, and merely detecting a cancer earlier than it would otherwise have been detected does not necessarily mean improved outcomes. To understand this, we need to understand three important biases inherent to screening studies
A group led by @drsabita & @docpriyar set out to look at the impact of COVID_19 on physicians in India from a gender perspective, our hypothesis being that a greater burden of familial/domestic responsibilities fell on women. Full paper: ascopubs.org/doi/pdf/10.120… 1/n
The #COVID_19 pandemic had realigned our lives, and for many, especially in healthcare, increased their work considerably. Healthcare workers globally found themselves working overtime to handle the pandemic, while their domestic work increased thanks to the lockdown 2/n
This survey of over a 1000 Indian physicians confirmed our fears that the burden of running the family and domestic chores were indeed disproportionately handled by women. While this was not completely unexpected, the magnitude of the inequity was striking 3/n
#SARSCov_2 viral variants / mutants and vaccination seem to be consuming most discussions on #COVID_19 these days. We’ve let incomplete data and general knowledge create misinformation and confusion amongst us all. An explanatory thread...
We’ve heard of the #Delta, the #DeltaPlus & unknown future variants which may be either more transmissible or more lethal than previous ones. This has either created panic, or worse, a sense of futility about both vaccines and precautionary measures to avoid the infection
The chatter about variants and mutants is fascinating, but linking them to the futility of getting over this pandemic is dangerous. An unfortunate line of thought seems to be that if these viruses mutate and vaccines are ineffective against them, why bother getting vaccinated?
The worst of the second wave of #COVID_19 seems to be behind us in India. Here are some random thoughts…
Let’s face it – the second wave caught all of us by surprise by the sheer ferocity with which it unleashed itself. The inadequacies and frailties of our healthcare systems lay exposed. After nearly three months of helplessness, we are limping back to some semblance of control.
The key for our immediate future and that of our children is how we handle the next few months. For starters, we are not yet out of the woods with the second wave
We looked at volumes of services in 41 cancer centres that were part of the @CancerGridIndia over a 3 month period during the pandemic in 2020 and the same 3 months in 2019.
These 41 centres treat exactly one-third of all patients with cancer in India – approximately 450,000 new patients every year. So, our study was fairly representative of what was happening in the country (and probably many other parts of the world)
There has been a lot of panic in India about the “black fungus” which has caused substantial concern, morbidity and even deaths in patients with COVID. This is a short thread to explain what we know about it
The truth is that we don’t know everything about it, but let’s start by calling it what it is – “Mucor”. And anybody who claims that they know all about it is hmm…., let's say, “factually incorrect”
First, how does mucor spread & how do patients with #COVID-19 get infected with it? Mucor is a fungal infection caused by “mucormycetes”, a group of fungi. These fungi are ubiquitous – in soil, fallen leaves, compost, and air. Yet, most of us don’t develop the disease